Cargando…
Multidrug-resistant Tuberculosis Detection, Latvia
To improve multidrug-resistant tuberculosis (MDR-TB) detection, we successfully introduced the rpoB gene mutation line probe assay into the national laboratory in Latvia, a country with epidemic MDR-TB. The assay detected rifampin resistance with 91% sensitivity and 96% specificity within 1 to 5 day...
Autores principales: | Skenders, Girts, Fry, Alicia M., Prokopovica, Inga, Greckoseja, Silvija, Broka, Lonija, Metchock, Beverly, Holtz, Timothy H., Wells, Charles D., Leimane, Vaira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310615/ https://www.ncbi.nlm.nih.gov/pubmed/16229783 http://dx.doi.org/10.3201/eid1109.041236 |
Ejemplares similares
-
Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia
por: Stagg, Helen R., et al.
Publicado: (2016) -
The value of effective public tuberculosis treatment: an analysis of opportunity costs associated with multidrug resistant tuberculosis in Latvia
por: Miller, Thaddeus L, et al.
Publicado: (2013) -
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
por: Skripconoka, Vija, et al.
Publicado: (2013) -
Multidrug-resistant Tuberculosis in Military Recruits
por: Freier, Grace, et al.
Publicado: (2006) -
Multidrug-Resistant Mycobacterium tuberculosis, Southwestern Colombia
por: Ferro, Beatriz E., et al.
Publicado: (2011)